Sphere (347700) Fundamentals 2026 — P/E 20.0x, Revenue Analysis | SniperIQ
Sphere (347700) is a KR-listed Healthcare company in Medical - Healthcare Information Services with a market capitalization of ₩568.3B, trading at ₩17300.00 on the KOE. This SniperIQ fundamentals page covers Sphere's valuation (P/E 20.0x, P/B 7.6x), profitability (net margin 31.0%), revenue (₩95.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Sphere's market cap?
Sphere (347700) has a market capitalization of approximately ₩568.3B, trading at ₩17300.00 on the KOE. Market cap moves with the live share price.
What is Sphere's P/E ratio?
Sphere's trailing twelve-month P/E ratio is 20.0x, with a price-to-book (P/B) of 7.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Sphere?
Sphere runs a net profit margin of 31.0%, a gross margin of 15.3%, and an operating margin of 4.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Sphere generate?
Sphere reported revenue of ₩95.6B for fiscal year 2025, with net income of ₩170M and earnings per share (EPS) of 5.18. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Sphere pay a dividend?
Sphere does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Sphere financially healthy?
Sphere carries a debt-to-equity ratio of 3.35x and a current ratio of 0.27x, with a market beta of 0.76. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Sphere a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Sphere (347700) the key facts are: market cap ₩568.3B, P/E 20.0x, revenue ₩95.6B, 52-week range 7050-57300. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Sphere's full fundamentals live
Get Sphere's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.